Art. 98 Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 20…

Transitional provision

In forcesince 16 Apr 2014cited 3×
1.

By way of derogation from Article 96(1) of this Regulation, where the request for authorisation of a clinical trial has been submitted before the date referred to in the second paragraph of Article 99 of this Regulation pursuant to Directive 2001/20/EC, that clinical trial shall continue to be governed by that Directive until three years from that date.

2.

By way of derogation from Article 96(1) of this Regulation, where the request for authorisation of a clinical trial is submitted between six months after the date of publication of the notice referred to in Article 82(3) of this Regulation and 18 months after the date of publication of that notice, or, if the publication of that notice occurs earlier than 28 November 2015, where that request is submitted between 28 May 2016 and 28 May 2017, that clinical trial may be started in accordance with Articles 6, 7 and 9 of Directive 2001/20/EC. That clinical trial shall continue to be governed by that Directive until 42 months after the date of publication of the notice referred to in Article 82(3) of this Regulation, or, if that publication occurs earlier than 28 November 2015, until 28 May 2019.

  • Regulation (EU) 2017/156926Law

    … 34).], в съответствие с преходните разпоредби, установени в член 98 от Регламент (ЕС) № 536/2014.

  • Regulation (EU) 2017/55616Law

    … да се прилага за клиничните изпитвания, които в съответствие с член 98 от Регламент (ЕС) № 536/2014 се уреждат от Директива 2001/20/ЕО.

  • Regulation (EU) 2022/2011Law

    … посочена в членове 3 и 4, до края на преходния период, предвиден в член 98 от Регламент (ЕС) № 536/2014. 6. Клиничните изпитвания, при които …